8-K/A

OXIGENE, INC.

Company: Oncotelic Therapeutics, Inc.
Filed: June 26, 2006
Period of Report: June 14, 2006
Accession Number: 0000950135-06-004085

View Document ↗ View on SEC.gov ↗